Just when you thought the circular deals couldn’t get any more circular, OpenAI has invested in CEO Sam Altman’s brain computer interface (BCI) startup Merge Labs. Merge Labs, which defines itself as ...

On Thursday, OpenAI announced its investment in neurotech startup Merge Labs, cofounded by its CEO, billionaire Sam Altman. OpenAI will collaborate with the new venture to develop technology to link ...

The risks of using generative artificial intelligence to educate children and teens currently overshadow the benefits, according to a new study by the Brookings Institution's Center for Universal ...

OpenAI CEO Sam Altman’s new brain-computer interface startup, Merge Labs, is being spun out of the Los Angeles–based nonprofit Forest Neurotech, according to a source with direct knowledge of the ...

Altman taps a leading researcher for his brain-computer interface startup, suggesting a much less invasive approach than Elon Musk’s Neuralink. Altman taps a leading researcher for his brain-computer ...

It’s a well-worn adage of the Internet age: people often aren’t what they seem to be online. But until recently, you could at least be assured that they were people. Now, though, “chatfishing,” a new ...

I would like to add the most famous problem of the interviews and different coding platforms as it comes as the daily challenge on platforms and we can only perform the merge sort on the linked list ...

Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...

Russia has resorted to using decades old Nazi weapons in its war on Ukraine as the Kremlin has been forced to raid museums to help rearm and restock its meat grinder war machine. Ukraine’s “Tur” ...

Sept 2 (Reuters) - Drug developers are increasing adoption of AI technologies for discovery and safety testing to get faster and cheaper results, in line with an FDA push to reduce animal testing in ...